Roger Dansey
Patrimonio netto: 66 022 $ in data 30/06/2026
Patrimonio netto: 66 022 $ in data 30/06/2026
Attualmente, Roger D. Dansey occupa la posizione di responsabile medico di Seagen Inc. In passato il dottor Dansey ha ricoperto la posizione di vicepresidente della ricerca clinica oncologica presso Gilead Sciences, Inc. e SVP & Head-Therapeutic Area presso Merck Research Laboratories Massachusetts LLC. Il Dr. Dansey ha ricevuto un dottorato dall'Università del Witwatersrand.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/04/2026 | 13.258 ( 0,03% ) | 56 214 $ | 30/06/2026 | |
| 20/05/2026 | 8.916 ( 0,01% ) | 9 808 $ | 30/06/2026 | |
| 15/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 13/05/2021 |
| BICYCLE THERAPEUTICS PLC | Direttore/Membro del Consiglio | 08/09/2025 |
| NURIX THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 10/11/2025 |
Inovio, Inc.
Inovio, Inc. Packaged SoftwareTechnology Services Operates as an online payment platform | Direttore/Membro del Consiglio | - |
Ultrahuman Eight Ltd.
Ultrahuman Eight Ltd. Pharmaceuticals: MajorHealth Technology Manufactures cancer-related medicine | Direttore/Membro del Consiglio | - |
Shasqi, Inc.
Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| KRONOS BIO, INC. | Direttore/Membro del Consiglio | 20/06/2025 |
| PFIZER INC. | Corporate Officer/Principal | 05/02/2025 |
| SEAGEN INC. | Amministratore Delegato | 09/11/2022 |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
University of the Witwatersrand
University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Inovio, Inc.
Inovio, Inc. Packaged SoftwareTechnology Services Operates as an online payment platform | Technology Services |
Bicycle Therapeutics Plc
Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
Kronos Bio, Inc.
Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Shasqi, Inc.
Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Ultrahuman Eight Ltd.
Ultrahuman Eight Ltd. Pharmaceuticals: MajorHealth Technology Manufactures cancer-related medicine | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale